Inc.

Sinclair and Reading Is Fundamental Launch Sinclair Cares: Supporting Children’s Literacy

Retrieved on: 
Monday, March 4, 2024

Sinclair Inc. (Nasdaq: SBGI) today announced a partnership with Reading Is Fundamental ( RIF ), the nation’s leading children’s literacy nonprofit, to launch Sinclair Cares: Supporting Children’s Literacy .

Key Points: 
  • Sinclair Inc. (Nasdaq: SBGI) today announced a partnership with Reading Is Fundamental ( RIF ), the nation’s leading children’s literacy nonprofit, to launch Sinclair Cares: Supporting Children’s Literacy .
  • The Sinclair Cares: Supporting Children’s Literacy campaign will run throughout March, National Reading Month.
  • Since 1966, Reading Is Fundamental (RIF), has provided nearly 430 million books and reading resources to over 160 million children.
  • In addition, the Sinclair Cares: Supporting Children’s Literacy campaign will also be supported by a $25,000 donation from Sinclair.

Veradigm to Participate in Barclays 26th Annual Global Healthcare Conference

Retrieved on: 
Monday, March 4, 2024

Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm interim Chief Executive Officer and board member, Lee Westerfield, interim Chief Financial Officer, and Will Manidis, Senior Vice President and the former CEO of ScienceIO, will participate in a fireside chat and investor Q&A, as well as meet with investor attendees during the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13th, 2024 at 2:05 PM EDT.

Key Points: 
  • Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm interim Chief Executive Officer and board member, Lee Westerfield, interim Chief Financial Officer, and Will Manidis, Senior Vice President and the former CEO of ScienceIO, will participate in a fireside chat and investor Q&A, as well as meet with investor attendees during the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13th, 2024 at 2:05 PM EDT.
  • The webcast will be available in the investor section of the company's website at investor.veradigm.com , with an archived version accessible later that same day.

Ecolab Named One of the World’s Most Ethical Companies for 18th Consecutive Year

Retrieved on: 
Monday, March 4, 2024

Ecolab has earned the title for 18 consecutive years since Ethisphere’s inaugural award in 2007.

Key Points: 
  • Ecolab has earned the title for 18 consecutive years since Ethisphere’s inaugural award in 2007.
  • “At Ecolab, we consider ethical business practices to be a cornerstone of what it means to be a responsible and profitable company,” said Christophe Beck, Chairman and CEO, Ecolab.
  • In determining its list of the World’s Most Ethical Companies, Ethisphere conducts qualitative and quantitative assessments of companies across five categories.
  • To access the complete list of Ethisphere’s 2024 World's Most Ethical Companies, visit: worldsmostethicalcompanies.com/honorees .

Veradigm Completes Acquisition of ScienceIO

Retrieved on: 
Monday, March 4, 2024

Veradigm Inc. (OTCMKTS: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, today announced that it has completed its acquisition of ScienceIO, a leading AI platform and foundation model provider for the healthcare ecosystem.

Key Points: 
  • Veradigm Inc. (OTCMKTS: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, today announced that it has completed its acquisition of ScienceIO, a leading AI platform and foundation model provider for the healthcare ecosystem.
  • “This is an exciting day as we announce that we officially closed the ScienceIO transaction,” said Dr. Yin Ho, Veradigm’s Interim CEO and a member of the Company’s Board.
  • “By combining ScienceIO’s healthcare-specific large language model (LLM) with our rich dataset, we expect to be able to accelerate the speed at which we can deliver insights from unstructured data across the healthcare ecosystem to our customers.
  • We strongly believe this will further elevate the value delivered by the Veradigm Network.”

MB2 Dental Ranks #102 on the 2024 Inc. Regionals: Southwest List

Retrieved on: 
Friday, March 1, 2024

MB2 Dental , the first and largest Dental Partnership Organization (DPO) nationwide, announced today it ranked #102 on the 2024 Inc. Regionals Southwest list.

Key Points: 
  • MB2 Dental , the first and largest Dental Partnership Organization (DPO) nationwide, announced today it ranked #102 on the 2024 Inc. Regionals Southwest list.
  • This marks the third year in which MB2 Dental appeared on the Inc. Regionals Southwest list, which evaluates companies based in Arizona, New Mexico, Oklahoma and Texas.
  • MB2 Dental was one of 47 Dallas-Fort Worth metro area companies that made the list and within those, one of 12 in the healthcare industry.
  • The Inc. Regionals program ranks companies according to the percentage growth rate of their annual revenue over a two-year period.

Rambus Initiates Accelerated Share Repurchase Program

Retrieved on: 
Friday, March 1, 2024

Rambus Inc. (NASDAQ: RMBS ), a premier chip and silicon IP provider making data faster and safer, today announced that it initiated an accelerated share repurchase program with Royal Bank of Canada, through its agent RBC Capital Markets, LLC (“Dealer”) to repurchase an aggregate of approximately $50 million of its common stock.

Key Points: 
  • Rambus Inc. (NASDAQ: RMBS ), a premier chip and silicon IP provider making data faster and safer, today announced that it initiated an accelerated share repurchase program with Royal Bank of Canada, through its agent RBC Capital Markets, LLC (“Dealer”) to repurchase an aggregate of approximately $50 million of its common stock.
  • “As part of our ongoing capital allocation strategy and commitment to increasing stockholder value, this share repurchase program reflects the strength of our balance sheet and cash generation, and demonstrates our continued confidence in the long-term growth of the company,” said Luc Seraphin, president and chief executive officer at Rambus.
  • Under the accelerated share repurchase program, Rambus will pre-pay $50 million to Dealer and receive an initial delivery of approximately 675,000 shares of its common stock within the first week of the program.
  • The accelerated share repurchase program is part of the broader share repurchase program previously authorized by the Rambus Board of Directors.

Digital Matter Completes Ubilite UBI206 Evaluation and Issues a Purchase Order for the UBI206 Ultra Low Power Wi-Fi Chips

Retrieved on: 
Friday, March 1, 2024

Ubilite Inc. (“Ubilite”) announced UBI206 was selected by Digital Matter, Perth, AUS for its Wi-Fi Indoor Location Products.

Key Points: 
  • Ubilite Inc. (“Ubilite”) announced UBI206 was selected by Digital Matter, Perth, AUS for its Wi-Fi Indoor Location Products.
  • The Ubilite team developed the UBI206 Wi-Fi chip with power consumption that rivals BLE (Bluetooth Low Energy) removing the tradeoff between rich high data rate application experience and power consumption.
  • The revolutionary chip architecture was designed from the ground up to achieve ultra low power consumption with a very small design footprint with minimal external components resulting in a very low bill of materials cost.
  • The UBI206 is a highly integrated single die (SOC) that enables a vast number of IoT products with minimal number of external components.

Neurogene to Participate in Upcoming Investor Conferences

Retrieved on: 
Thursday, February 29, 2024

Neurogene Inc. (NASDAQ: NGNE) (“Neurogene” or “the Company”), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the following investor conferences:

Key Points: 
  • Neurogene Inc. (NASDAQ: NGNE) (“Neurogene” or “the Company”), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the following investor conferences:
    Date: Tuesday, March 5 at 10:30 a.m.
  • ET
    Date: Wednesday, March 20 at 9:30 a.m.
  • ET
    Live webcasts of the panel and fireside chat can be accessed from the Investor Relations section of Neurogene’s website under events , where a replay of the events will also be available for a limited time.

Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults

Retrieved on: 
Thursday, February 29, 2024

Pfizer Inc. (NYSE: PFE) today announced top-line ABRYSVO® vaccine efficacy and safety data for respiratory syncytial virus (RSV) in adults 60 years of age and older following a second season in the Northern and Southern Hemispheres from the ongoing pivotal Phase 3 clinical trial ( NCT05035212 ) RENOIR (RSV vaccine Efficacy study iN Older adults Immunized against RSV disease).

Key Points: 
  • Pfizer Inc. (NYSE: PFE) today announced top-line ABRYSVO® vaccine efficacy and safety data for respiratory syncytial virus (RSV) in adults 60 years of age and older following a second season in the Northern and Southern Hemispheres from the ongoing pivotal Phase 3 clinical trial ( NCT05035212 ) RENOIR (RSV vaccine Efficacy study iN Older adults Immunized against RSV disease).
  • Vaccine efficacy against RSV-associated lower respiratory tract disease (LRTD), defined by three or more symptoms, after disease surveillance in season two was 77.8% (95.0% CI: 51.4, 91.1); vaccine efficacy following season one was 88.9% (95.0% CI: 53.6%, 98.7%)1, which demonstrates durable efficacy after two seasons.
  • Consistent vaccine efficacy was demonstrated for both RSV A and RSV B after season two with vaccine efficacy against each subtype of ≥80% for LRTD with three or more symptoms.
  • No new adverse events were reported through the second RSV season beyond what was reported by subjects in the clinical trial during the first season.

Belden Launches New Solutions to Enable Better Connectivity, Faster Speeds and More Power for Mission-Critical Environments

Retrieved on: 
Thursday, February 29, 2024

Belden Inc. (NYSE: BDC), a leading global supplier of network infrastructure and digitization solutions, announces new products designed to help mission-critical environments perform at their peak.

Key Points: 
  • Belden Inc. (NYSE: BDC), a leading global supplier of network infrastructure and digitization solutions, announces new products designed to help mission-critical environments perform at their peak.
  • Belden Horizon Console updates include enhancements that allow organizations to take greater control of data collection and transfer.
  • Industrial environments can now use Belden Horizon to send OT data to their cloud service for analysis; they can also support connectivity for multiple remote networks through one Console connection.
  • To learn more about these solutions, as well as the types of technology and applications they support, visit www.belden.com/new-products .